Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Depreciation & Amortization (CF) (2020 - 2025)

Definitive Healthcare's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $991000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 88.4% year-over-year to $991000.0; the TTM value through Dec 2025 reached $3.3 million, up 47.13%, while the annual FY2025 figure was $3.3 million, 47.13% up from the prior year.
  • Depreciation & Amortization (CF) reached $991000.0 in Q4 2025 per DH's latest filing, up from $853000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $991000.0 in Q4 2025 to a low of $341000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $572250.0, with a median of $540000.0 recorded in 2024.
  • Peak YoY movement for Depreciation & Amortization (CF): tumbled 38.65% in 2023, then surged 88.4% in 2025.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $558000.0 in 2021, then dropped by 15.41% to $472000.0 in 2022, then rose by 19.07% to $562000.0 in 2023, then fell by 6.41% to $526000.0 in 2024, then soared by 88.4% to $991000.0 in 2025.
  • Per Business Quant, the three most recent readings for DH's Depreciation & Amortization (CF) are $991000.0 (Q4 2025), $853000.0 (Q3 2025), and $868000.0 (Q2 2025).